Je was op zoek naar: hyaline (Engels - Deens)

hyaline
hyalin

hyaline cavity
hyalint hulrum

hyaline connective tissue
hyalint bindevæv

megalencephaly with hyaline panneuropathy
alexanders sygdom

table 4: select efficacy endpoints for hyaline vascular subgroup from study 1
tabel 4: udvalgte endepunkter for effekt for den hyaline vaskulære undergruppe fra studie 1

select efficacy results from study 1 in the hyaline vascular subgroup are summarised in table 4.
udvalgte effektresultater fra studie 1 i den hyaline vaskulære undergruppe er gengivet i tabel 4.

a consistent treatment effect favouring siltuximab treated patients across all major secondary endpoints was shown in the hyaline vascular subgroup.
i den hyaline vaskulære subtype sås en konsistent behandlingseffekt til fordel for siltuximabbehandlede patienter for alle væsentlige sekundære endepunkter.

histological subtype was similar in both treatment arms, with 33% hyaline vascular subtype, 23% plasmacytic subtype and 44% mixed subtype.
den histologiske subtype ens i begge behandlingsarme, med 33 % hyalin-vaskulær subtype, 23 % plasmacytisk subtype og 44 % blandet subtype.

persistent pulmonary hypertension of the newborn (pphn) occurs as a primary developmental defect or as a condition secondary to other diseases such as meconium aspiration syndrome (mas), pneumonia, sepsis, hyaline membrane disease, congenital diaphragmatic hernia (cdh), and pulmonary hypoplasia.
persisterende, pulmonal hypertension hos nyfødte (pphn) optræder som en primær udviklingsdefekt eller som en tilstand sekundær til andre sygdomme så som mekonium-aspirationssyndrom (mas), pneumoni, sepsis, hyalinmembran-sygdom, medfødt diafragmahernie (congenital diaphragmatic hernia (cdh)) og pulmonal hypoplasi.